Xlife Sciences AG (Xlife Sciences AG) Days Sales Outstanding : 1,404.02 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Xlife Sciences AG Days Sales Outstanding?

Xlife Sciences AG's average Accounts Receivable for the six months ended in Dec. 2023 was $5.69 Mil. Xlife Sciences AG's Revenue for the six months ended in Dec. 2023 was $0.74 Mil. Hence, Xlife Sciences AG's Days Sales Outstanding for the six months ended in Dec. 2023 was 1,404.02.

The historical rank and industry rank for Xlife Sciences AG's Days Sales Outstanding or its related term are showing as below:

XLSCF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 176.84 Med: 1009.24 Max: 1786.58
Current: 1283.29

During the past 6 years, Xlife Sciences AG's highest Days Sales Outstanding was 1786.58. The lowest was 176.84. And the median was 1009.24.

XLSCF's Days Sales Outstanding is ranked worse than
96.41% of 892 companies
in the Biotechnology industry
Industry Median: 72.29 vs XLSCF: 1283.29

Xlife Sciences AG's Days Sales Outstanding increased from Dec. 2022 (135.32) to Dec. 2023 (1,404.02).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Xlife Sciences AG Days Sales Outstanding Historical Data

The historical data trend for Xlife Sciences AG's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xlife Sciences AG Days Sales Outstanding Chart

Xlife Sciences AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

1,007.93

1,151.34

179.37

183.82

1,780.09

Xlife Sciences AG Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial					146.89	234.68	135.32	334.98	1,404.02

Competitive Comparison of Xlife Sciences AG's Days Sales Outstanding

For the Biotechnology subindustry, Xlife Sciences AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xlife Sciences AG's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xlife Sciences AG's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Xlife Sciences AG's Days Sales Outstanding falls into.

Xlife Sciences AG Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Xlife Sciences AG's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.585	+	10.554)	/	2 )	/	1.142	*	365
=	5.5695					/	1.142	*	365
=	1,780.09

Xlife Sciences AG's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.832	+	10.554)	/	2 )	/	0.74	*	365 / 2
=	5.693					/	0.74	*	365 / 2
=	1,404.02

Xlife Sciences AG (GREY:XLSCF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Xlife Sciences AG Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Xlife Sciences AG's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Xlife Sciences AG (Xlife Sciences AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xlife Sciences AG (GREY:XLSCF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

XLS:Switzerland

Address

Talacker 35, Zürich, CHE, 8001

Website

https://www.xlifesciences.ch

Xlife Sciences AG is a Swiss company with a focus on performance technologies in life sciences. The company allows its investors a very early and direct Entry into the further development of innovative and future-oriented technologies.

Xlife Sciences AG (Xlife Sciences AG) Headlines

From GuruFocus

Xlife Sciences AG: Successful License Deal with Vitese Trading GmbH

By ACCESSWIRE ACCESSWIRE • 10-07-2021

Xlife Sciences AG: Breakthrough in Drug Development

By ACCESSWIRE ACCESSWIRE • 06-10-2021

Xlife Sciences AG: curasan AG and Xlife Sciences AG Cooperate in the Field of Regenerative Medicine

By ACCESSWIRE ACCESSWIRE • 06-16-2021

Xlife Sciences AG: Xlife Sciences AG is Elected as Innovation Partner for Saudi Arabia

By ACCESSWIRE ACCESSWIRE • 10-26-2021

Xlife Sciences AG Plans Listing on the 'Sparks' Segment of SIX Swiss Exchange

By ACCESSWIRE ACCESSWIRE • 01-10-2022